Results 101 to 110 of about 174,156 (175)

Efficacy and Safety of Syk and BTK Inhibitors in Immune Thrombocytopenia: A Comprehensive Review of Emerging Evidence. [PDF]

Mediators Inflamm
Heidari A, Mazid AS, Behroozfar M, Ghotbi N, Fathabadi F, Eghbali S, Heidari N.   +6 more
europepmc   +1 more source

A Comparative Analysis of Cardiovascular Events Associated With Acalabrutinib Versus Ibrutinib in Chronic Lymphocytic Leukemia: Insights From a Global Federated Network. [PDF]

Pharmacol Res Perspect
Majrashi A, Gue YX, Shantsila A, Williams S, Smith CT, Lip GYH, Pettitt AR.   +6 more
europepmc   +1 more source

The BMX Tyrosine Kinase : A Signal Mediator in Hematopoietic and Endothelial/Epithelial Cells [PDF]

, 2003
Ekman, Niklas
core  

Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre‐B cell stage.

EMBO Journal, 1996
Rudolf W Hendriks, M. F. T. R. D. Bruijn, A. Maas, G. Dingjan, A. Karis, Frank Grosveld   +5 more
semanticscholar   +1 more source

Navigating the complex terrain of hepatitis B virus reactivation in the era of Bruton tyrosine kinase inhibitors. [PDF]

World J Gastroenterol
Liu WN, Dai MS, Lin F, Lin GM.
europepmc   +1 more source

Mycoplasma pneumonia in a patient with X-linked agammaglobulinemia. [PDF]

BMC Infect Dis
Dai B, Han S, Shen Y, Li Z, Chen S, Wang Z, Yuan Y, Zhang R, Wang C, Zheng J, Liang Q, Wang Q, Zhang Y, Zhang X, Wang F, Jin Y.   +15 more
europepmc   +1 more source

Comparative efficacy of Bruton tyrosine kinase inhibitors in high-risk relapsed/refractory CLL: a network meta-analysis. [PDF]

Blood Adv
Shadman M, Brown JR, Mohseninejad L, Yang K, Burnett H, Neupane B, Williams R, Lamanna N, O'Brien SM, Tedeschi A, Tam CS.   +10 more
europepmc   +1 more source

Target discovery: Blocking BTK in B-cell disorders

Nature reviews. Drug discovery, 2010
Alexandra Flemming
semanticscholar   +1 more source

High-risk stays high-risk: Bruton tyrosine kinase inhibitors in B-cell malignancies. [PDF]

Haematologica
Al-Sawaf O.
europepmc   +1 more source

Bruton Tyrosine Kinase in Lesions of Multiple Sclerosis and 3 of Its Models. [PDF]

Neurol Neuroimmunol Neuroinflamm
Li C, Morch MT, Gorter R, Lozinski B, Ghorbani S, Dong Y, Shen YA, Harp C, Zandee S, Klement W, Prat A, Yong VW.   +11 more
europepmc   +1 more source